Tarsus Pharmaceuticals, Inc. TARS Warrants and Rights Outstanding
Warrants and Rights Outstanding at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s warrants and rights outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s warrants and rights outstanding?
- Tarsus Pharmaceuticals, Inc. (TARS) reported warrants and rights outstanding of 312.5K in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s warrants and rights outstanding changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s warrants and rights outstanding decreased by 0.0% year-over-year, from 312.5K to 312.5K.
- What does warrants and rights outstanding mean?
- This represents the total number or value of outstanding warrants and rights that grant holders the option to purchase company shares at a specified price. These instruments represent potential future dilution to existing shareholders upon exercise. Analyzing this is critical for evaluating the company's capital structure and potential future equity issuance.